June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Sodium hyaluronate improves corneal reinnervation and epithelial healing in an in vivo BAK-induced toxicity model
Author Affiliations & Notes
  • Melina del Papa
    Medical affairs, Laboratorios Poen, Buenos Aires, Buenos Aires, Argentina
  • Alexia Vereertbrugghen
    Innate Immunity Laboratory, Institute of Experimental Medicine CONICET-ANM, Buenos Aires, Buenos Aires, Argentina
  • Manuela Pizzano
    Innate Immunity Laboratory, Institute of Experimental Medicine CONICET-ANM, Buenos Aires, Buenos Aires, Argentina
  • María Silvia Passerini
    Medical affairs, Laboratorios Poen, Buenos Aires, Buenos Aires, Argentina
  • Jeremias Gaston Galletti
    Innate Immunity Laboratory, Institute of Experimental Medicine CONICET-ANM, Buenos Aires, Buenos Aires, Argentina
  • Footnotes
    Commercial Relationships   Melina del Papa Poen Laboratories, Code E (Employment); Alexia Vereertbrugghen Poen Laboratories, Code F (Financial Support); Manuela Pizzano Poen Laboratories, Code F (Financial Support); María Silvia Passerini Poen Laboratories, Code E (Employment); Jeremias Galletti Poen Laboratories, Code F (Financial Support)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3111. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Melina del Papa, Alexia Vereertbrugghen, Manuela Pizzano, María Silvia Passerini, Jeremias Gaston Galletti; Sodium hyaluronate improves corneal reinnervation and epithelial healing in an in vivo BAK-induced toxicity model. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3111.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the protective effect of 0.4% sodium hyaluronate on benzalkonium chloride-induced toxicity using an in vivo model.

Methods : 88 Balb/c mice were divided into 4 groups: 1) Control: saline solution; 2) SH: 0.4% sodium hyaluronate 3 times a day; 3) BAK: benzalkonium chloride 0.01% twice a day; 4) SH+BAK: SH 0.4% 3 times a day + BAK 0.01% twice a day. All groups received 3 daily instillations (8AM, 2PM, and 8PM). For the SH+BAK group, SH was administered first and BAK was administered 10 minutes later. The dosing scheme began 48 hours before time 0 when a controlled, 1.5 mm-diameter corneal ulcer was made under a surgical microscope in the right eye of all mice. The dosing schedule continued for 10 days. After this period, all mice were sacrificed and the corneal nerve plexus was analyzed by confocal microscopy, with βIII tubulin immunostaining. Wound healing over time and corneal nerve regeneration using Sholl analysis were assessed. Data were analyzed by two-way ANOVA.

Results : Wound closure: There were statistically significant differences in ulcer closure between treatment groups over time (p<0.0001). Mice treated with BAK show slower healing than those treated with SH+BAK (p=0.0124).The AUC of corneal cicatrization for Control group was 19.7±2.5; for SH 20.1±2.7; for BAK 28.0±4.6, and for SH+BAK 24.4±5.0 (p<0.001). All ulcers closed within 72 hours of injury. The media of hour of wound closure was: 41.5±9.6 for control group; 39.3±7.6 for SH group; 51.3±9.9 for BAK group, and 45.8±8.8 for SH+BAK group. (p<0.001).

Corneal nerve regeneration: The neural network presented an increasing complexity in the groups: BAK < BAK+SH < CONTROL < SH. Considering the largest radius analyzed (100 µm), the number of intersections was: 11.5 ± 2.6 in Control group; 15.8 ±2.1 in SH; 5.1 ± 2.2 in BAK, and 8.05 ± 2.2 in SH+BAK (p <0.05). The AUC of corneal cicatrization for Control group was 19.7±2.5; for SH 20.1±2.7; for BAK 28.0±4.6, and for SH+BAK 24.4±5.0 (p<0.001). All ulcers closed within 72 hours of injury. The media of hour of wound closure was: 41.5±9.6 for control group; 39.3±7.6 for SH group; 51.3±9.9 for BAK group, and 45.8±8.8 for SH+BAK group (p<0.001).

Conclusions : BAK has a toxic action both on epithelial regeneration and corneal nerve plexus.
The concomitant addition of SH protects against the toxic action of BAK, promoting epithelial healing and corneal nerve regeneration.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×